Methamphetamine addiction treatment for the highly addictive substance is available. Long term treatment centers have been very effective in overcoming methamphetamine addiction. These programs may include medical detoxification, in which the person is treated by a medical team and made comfortable while stopping the use of methamphetamines. They also may include 12-step program meetings, individual and group counseling, family therapy, relapse prevention, and after care programs.
Many times an addict may not always throw his hands up and give up his addiction to methamphetamines, in which case an intervention may be necessary. An intervention is when members of the family or close friends all come together with a goal; make the dependent more aware of his illness.
When exposed to intensive group therapies and individual therapies that are aimed to promote the behavioral changes needed to remain abstinent, prevent relapse, and establish a full lifestyle change over a 16 week period; methamphetamine users have shown a significant improvement. Recovery is not just based around stopping usage. Recovery is about a full change, and improving a dependents future. By setting up long term goals in therapy and groups an addict is able to zone in and focus on overcoming addiction.
The brain is physically and chemically affected by methamphetamine use. Imaging studies have demonstrated changes in the dopamine system. This system is important for reward, motivation, and learning, as well as structural and functional deficits in brain areas associated with emotion and memory. The methamphetamine induced deficits in dopamine functions have been shown to recover, at least partially, over long periods of time. After prolonged use, it is suggested that the addict/dependent should participate in brain challenging activities such as drawing exercises, logic exercises, or fitness to naturally increase the stream of dopamine throughout the body.
There are currently no medications approved for Methamphetamine Addiction Treatment. A recent clinical trial revealed that the antidepressant bupropion, marketed as Wellbutrin effective in reducing methamphetamine abuse in low/moderate users. NIDA however, has made development of such medications a high priority. Such as the novel approach of using a vaccine to completely block the euphoria of the high entirely. Therefore the vaccine would reduce cravings by simply blocking the methamphetamines’ rewarding effects.